Antiepileptics Suicidality Alert Issued; Label Changes Likely

WASHINGTON — Food and Drug Administration findings of an increased risk of suicidality in patients given antiepileptic drugs likely will lead to broad class labeling changes, according to an FDA alert issued to health care professionals.